Apo-candesartan: Affected Lots Were Manufactured Using An Active Ingredient That Was Out Of Specification For Dissolution
Recall Summary APO-CANDESARTAN tablets are being recalled across Canada because certain batches were made with an active ingredient that didn't meet quality standards for how it dissolves in the body. This is a Class I recall, which means the affected product could cause serious health problems. The recall affects APO-CANDESARTAN products distributed throughout Canada.
- Product
- APO-CANDESARTAN
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-02-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/7244d75f-6085-4327-b3de-17f3c8a1fa32